The global conversation surrounding psychopharmacology, clinical psychiatry, and mental health management frequently intersects with inquiries about drug classes and therapeutic applications. As researchers, medical professionals, and public health advocates across the United States, Canada, Brazil, Mexico, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, and Switzerland evaluate various pharmaceutical and botanical agents, a common […]